Info@ThinkPinkRocks.com

Genocea announces new data that supports novel approach for development of HSV-2 vaccine

Genocea Biosciences announced today the presentation of new data supporting its novel approach to developing a first-in-class, protein subunit therapeutic vaccine for Herpes Simplex Virus type 2 (HSV-2).

Continue reading here:
Genocea announces new data that supports novel approach for development of HSV-2 vaccine

Share

Leave a Reply